205 related articles for article (PubMed ID: 28437839)
21. Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases.
Solé M; Unzeta M
Biol Cell; 2011 Nov; 103(11):543-57. PubMed ID: 21819380
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of semicarbazide-sensitive amine oxidases decreases lymphocyte infiltration in the early phases of rat liver allograft rejection.
Martelius T; Salmi M; Krogerus L; Loginov R; Schoultz M; Karikoski M; Miiluniemi M; Soots A; Höckerstedt K; Jalkanen S; Lautenschlager I
Int J Immunopathol Pharmacol; 2008; 21(4):911-20. PubMed ID: 19144276
[TBL] [Abstract][Full Text] [Related]
23. Obesity of mice lacking VAP-1/SSAO by Aoc3 gene deletion is reproduced in mice expressing a mutated vascular adhesion protein-1 (VAP-1) devoid of amine oxidase activity.
Jargaud V; Bour S; Tercé F; Collet X; Valet P; Bouloumié A; Guillemot JC; Mauriège P; Jalkanen S; Stolen C; Salmi M; Smith DJ; Carpéné C
J Physiol Biochem; 2021 Feb; 77(1):141-154. PubMed ID: 32712883
[TBL] [Abstract][Full Text] [Related]
24. Vascular adhesion protein-1 enhances neutrophil infiltration by generation of hydrogen peroxide in renal ischemia/reperfusion injury.
Tanaka S; Tanaka T; Kawakami T; Takano H; Sugahara M; Saito H; Higashijima Y; Yamaguchi J; Inagi R; Nangaku M
Kidney Int; 2017 Jul; 92(1):154-164. PubMed ID: 28318627
[TBL] [Abstract][Full Text] [Related]
25. A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte-endothelium interactions under shear stress.
Yegutkin GG; Salminen T; Koskinen K; Kurtis C; McPherson MJ; Jalkanen S; Salmi M
Eur J Immunol; 2004 Aug; 34(8):2276-85. PubMed ID: 15259025
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis.
Noda K; Miyahara S; Nakazawa T; Almulki L; Nakao S; Hisatomi T; She H; Thomas KL; Garland RC; Miller JW; Gragoudas ES; Kawai Y; Mashima Y; Hafezi-Moghadam A
FASEB J; 2008 Apr; 22(4):1094-103. PubMed ID: 18032635
[TBL] [Abstract][Full Text] [Related]
27. SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.
Unzeta M; Hernàndez-Guillamon M; Sun P; Solé M
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805974
[TBL] [Abstract][Full Text] [Related]
28. Synthetic liver X receptor agonist T0901317 inhibits semicarbazide-sensitive amine oxidase gene expression and activity in apolipoprotein E knockout mice.
Dai X; Ou X; Hao X; Cao D; Tang Y; Hu Y; Li X; Tang C
Acta Biochim Biophys Sin (Shanghai); 2008 Mar; 40(3):261-8. PubMed ID: 18330481
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity.
Wang EY; Gao H; Salter-Cid L; Zhang J; Huang L; Podar EM; Miller A; Zhao J; O'rourke A; Linnik MD
J Med Chem; 2006 Apr; 49(7):2166-73. PubMed ID: 16570912
[TBL] [Abstract][Full Text] [Related]
30. SSAO inhibitors suppress hepatocellular tumor growth in mice.
Li R; Li H; Luo HJ; Lin ZX; Jiang ZW; Luo WH
Cell Immunol; 2013; 283(1-2):61-9. PubMed ID: 23850964
[TBL] [Abstract][Full Text] [Related]
31. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in lipopolysaccharide-induced pulmonary inflammation.
Yu PH; Lu LX; Fan H; Kazachkov M; Jiang ZJ; Jalkanen S; Stolen C
Am J Pathol; 2006 Mar; 168(3):718-26. PubMed ID: 16507887
[TBL] [Abstract][Full Text] [Related]
32. Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia.
Sun P; Solé M; Unzeta M
Cerebrovasc Dis; 2014; 37(3):171-80. PubMed ID: 24503888
[TBL] [Abstract][Full Text] [Related]
33. VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke.
Hernandez-Guillamon M; Solé M; Delgado P; García-Bonilla L; Giralt D; Boada C; Penalba A; García S; Flores A; Ribó M; Alvarez-Sabin J; Ortega-Aznar A; Unzeta M; Montaner J
Cerebrovasc Dis; 2012; 33(1):55-63. PubMed ID: 22133888
[TBL] [Abstract][Full Text] [Related]
34. Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke.
Hernandez-Guillamon M; Garcia-Bonilla L; Solé M; Sosti V; Parés M; Campos M; Ortega-Aznar A; Domínguez C; Rubiera M; Ribó M; Quintana M; Molina CA; Alvarez-Sabín J; Rosell A; Unzeta M; Montaner J
Stroke; 2010 Jul; 41(7):1528-35. PubMed ID: 20538694
[TBL] [Abstract][Full Text] [Related]
35. Interaction of L-lysine and soluble elastin with the semicarbazide-sensitive amine oxidase in the context of its vascular-adhesion and tissue maturation functions.
Olivieri A; O'Sullivan J; Fortuny LR; Vives IL; Tipton KF
Biochim Biophys Acta; 2010 Apr; 1804(4):941-7. PubMed ID: 20079884
[TBL] [Abstract][Full Text] [Related]
36. Structure of human semicarbazide-sensitive amine oxidase/vascular adhesion protein-1.
Jakobsson E; Nilsson J; Ogg D; Kleywegt GJ
Acta Crystallogr D Biol Crystallogr; 2005 Nov; 61(Pt 11):1550-62. PubMed ID: 16239734
[TBL] [Abstract][Full Text] [Related]
37. Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis.
O'Rourke AM; Wang EY; Salter-Cid L; Huang L; Miller A; Podar E; Gao HF; Jones DS; Linnik MD
J Neural Transm (Vienna); 2007; 114(6):845-9. PubMed ID: 17393060
[TBL] [Abstract][Full Text] [Related]
38. Origins of serum semicarbazide-sensitive amine oxidase.
Stolen CM; Yegutkin GG; Kurkijärvi R; Bono P; Alitalo K; Jalkanen S
Circ Res; 2004 Jul; 95(1):50-7. PubMed ID: 15178639
[TBL] [Abstract][Full Text] [Related]
39. Vascular adhesion protein-1 inhibition provides antiinflammatory protection after an intracerebral hemorrhagic stroke in mice.
Ma Q; Manaenko A; Khatibi NH; Chen W; Zhang JH; Tang J
J Cereb Blood Flow Metab; 2011 Mar; 31(3):881-93. PubMed ID: 20877383
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema.
Inoue T; Morita M; Tojo T; Yoshihara K; Nagashima A; Moritomo A; Ohkubo M; Miyake H
Bioorg Med Chem; 2013 Mar; 21(5):1219-33. PubMed ID: 23337801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
